Repository logo
 
Publication

Academic labs supporting COVID‐19 diagnostics

2021Journal article Restricted access
Simple item page
dc.contributor.authorVeldhoen, Marc
dc.contributor.authorZuzarte-Luis, Vanessa
dc.date.accessioned2021-12-15T15:33:24Z
dc.date.available2021-12-15T15:33:24Z
dc.date.issued2021
dc.description© 2021 Wiley-VCH GmbHpt_PT
dc.description.abstractDespite news about the new virus SARS-CoV-2 and COVID-19 grabbing the headlines in the beginning of 2020, life and work carried on as normal in most academic labs. Lab projects were the focus, results discussed face-to-face and hypothesis dismissed. Conferences were attended in person and flights to the next meeting often booked already. By March, the seriousness became clear. With surrounding countries reporting increasing number of infections, the emergence of SARS-CoV-2 in Portugal was a matter of time, with the first two Portuguese cases reported at the start of March. Newspapers reported the cases with warnings not to be alarmist and that officials would calmly follow the evolution of the events (see here). However, how do you follow the spread of a virus, especially when it is new and capacity to detect it is limited?pt_PT
dc.description.sponsorshipWe like to acknowledge the funding from the European Union H2020 ERA project (No 667824 – EXCELLtoINNOV) and the Fundação para a Ciência e a Tecnologia (FCT) research4COVID19 (n° 231_596873172, Generating SARS-CoV2 seroconversion assay: n° 162_596842560, Test, Test, Test: Diagnostic of COVID-19 and n° 729, High-throughput SARS-CoV2 neutralising antibodies assessment).pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationEur J Immunol. 2021 Jan;51(1):13-16pt_PT
dc.identifier.doi10.1002/eji.202170015pt_PT
dc.identifier.eissn1521-4141
dc.identifier.issn0014-2980
dc.identifier.urihttp://hdl.handle.net/10451/50423
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherWileypt_PT
dc.relationLeverage research EXCELLence and INNOVation potential of Instituto de Medicina Molecular (IMM) through translational biomedical research in immunity and infection.
dc.relation.publisherversionhttps://onlinelibrary.wiley.com/journal/15214141pt_PT
dc.titleAcademic labs supporting COVID‐19 diagnosticspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleLeverage research EXCELLence and INNOVation potential of Instituto de Medicina Molecular (IMM) through translational biomedical research in immunity and infection.
oaire.awardURIinfo:eu-repo/grantAgreement/EC/H2020/667824/EU
oaire.citation.endPage16pt_PT
oaire.citation.issue1pt_PT
oaire.citation.startPage13pt_PT
oaire.citation.titleEuropean Journal of Immunologypt_PT
oaire.citation.volume51pt_PT
oaire.fundingStreamH2020
person.familyNameVeldhoen
person.familyNameZuzarte-Luis
person.givenNameMarc
person.givenNameVanessa
person.identifierhttps://scholar.google.pt/citations?hl=en&user=7vG1jLIAAAAJ
person.identifier.ciencia-id6413-A3A0-C7AD
person.identifier.ciencia-idE511-2580-B7B2
person.identifier.orcid0000-0002-1478-9562
person.identifier.orcid0000-0003-0023-5953
person.identifier.ridM-9105-2013
person.identifier.scopus-author-id8323789000
person.identifier.scopus-author-id6507946873
project.funder.identifierhttp://doi.org/10.13039/501100008530
project.funder.nameEuropean Commission
rcaap.rightsrestrictedAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublicationb6ddef66-b6bb-4ce5-b68a-e4b211aa2411
relation.isAuthorOfPublication6b0fe267-4183-4475-8bc8-df00b5341030
relation.isAuthorOfPublication.latestForDiscovery6b0fe267-4183-4475-8bc8-df00b5341030
relation.isProjectOfPublication7a4a0b51-ecdc-4c02-9d2b-0ac079311b63
relation.isProjectOfPublication.latestForDiscovery7a4a0b51-ecdc-4c02-9d2b-0ac079311b63

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Academic_COVID19.pdf
Size:
562.37 KB
Format:
Adobe Portable Document Format
Download

Collections

IMM - Artigos em Revistas Internacionais
FM - Artigos em Revistas Internacionais